Liz Kwo

Dr. Liz Kwo has 20+ years of experience in digital health, diagnostics, and medical management, with a focus on using data analytics to transform people’s daily lives and improve health outcomes at scale. Currently she is the Chief Medical Officer of Everly Health, an innovative home diagnostics company. Most recently, Dr. Kwo served as Deputy Chief Clinical Officer for Elevance (NYSE: ELV) and helped modernize disease management and care delivery for 43 million Americans. Prior to Elevance, Dr. Kwo started several venture backed companies as the CEO and co-founder of InfiniteMD (acquired by Consumer Medical that was acquired by Alight (NYSE: ALIT) and President and co-founder of New Pathway Education and Technology Group (acquired by EIC Education). Dr. Kwo is on the Board of Directors and Member of the Compensation Committee of Asensus (NYSE AMERICAN: ASXC), Chair of the Nomination, Governance and Compliance Committee of the Board of Directors of BlueWind Medical, and Chairman of the Board of Directors for ChroniSense. She is a practicing physician at Cambridge Health Alliance Hospital, a faculty lecturer at Harvard Medical School, and is board certified in Preventive Care and Occupational Medicine. She earned a BA in Human Biology from Stanford University, MD from Harvard Medical School, MBA from Harvard Business School, and an MPH from Harvard T.H. Chan School of Public Health.

Categories: , , , , , ,